Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 3 1Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 6Polycystic Ovary Syndrome 3Infertility 2Ovarian Hyperstimulation Syndrome 1Neoplasms 1Metabolic Syndrome 1Hypogonadism 1Fatty Liver 1

Interventions

Metformin 41Clomiphene 17Letrozole 6Menotropins 5Folic Acid 5drospirenone and ethinyl estradiol combination 4Liraglutide 4Chorionic Gonadotropin 4cetrorelix 3Triptorelin Pamoate 3Progesterone 3Pioglitazone 3Leuprolide 3Inositol 3Exenatide 3Ethinyl Estradiol 3Estradiol 3Vitamins 2Sperm Injections, Intracytoplasmic 2Sitagliptin Phosphate 2Simvastatin 2Gonadotropins 2Glycoprotein Hormones, alpha Subunit 2Exercise 2Escitalopram 2Cyproterone acetate, ethinyl estradiol drug combination 2Contraceptives, Oral 2Cholecalciferol 2Carnitine 2Canagliflozin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Polycystic Ovary Syndrome × Triptorelin Pamoate × Clear all
NCT04727671 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Damascus University

Phase 4 Completed
50 enrolled

Infertility, Polycystic Ovary Syndrome

NCT04727684 2023-10-24

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Damascus University

Phase 4 Completed
50 enrolled

Infertility, Polycystic Ovary Syndrome

NCT00417144 2006-12-29

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Eugonia

Phase 4 Unknown
200 enrolled
Gynecologic

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡